The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|December 14, 2014
Venair Launches New Biotech Division
Author(s)Pharmaceutical Technology Editors
Venair Biotech specializes in single-use products for the biotech and pharmaceutical sectors.
Advertisement
Venair, a manufacturer of silicone hoses, has launched a new business division, Venair Biotech, which will specialize in single-use products for the biotech, pharmaceutical, and scientific sectors, including investigational laboratories.
The new division will commercialize the single-use products in personalized packages that are customized to clients’ needs. Offerings include silicone hoses, sensors and fittings or valves.
Single-use products offer advantages such as reduction of contamination risks and more cost effective operations derived from the elimination of cleaning and validation procedures.
Source:
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement